REFERENCES

1. Maurer MS, et al. Circulation 2017;135:135-1377.
2. Connors LH, et al. Circulation 2016;133:282-290.
3. Grogan M, et al. J Am Coll Cardiol 2016;68:1014-1020.
4. Mints YY, et al. ESC Heart Fail 2018;5:772-779.
5. Maurer MS, et al. J Am Coll Cardiol 2016;68:161-172.
6. Nativi-Nicolau J, Maurer MS. Curr Opin Cardiol 2018;33:571-579.
7. Coelho T, et al. Curr Med Res Opin 2013;29:63-76.
8. Siddiqi OK, Ruberg FL. Trends Cardiovasc Med 2018;28.10-21.
9. Witteles RM, et al. JACC Heart Fail 2019,7:709-716.
10. Bishop E, et al. Amyloid 2018;25:174-179.
11. Pinney JH, et al. J Am Heart Assoc 2013;2:e000098.
12. Gonzalez-Lopez E, et al. Eur Heart J 2015;36:2585-2594.
13. Sipe JD, et al. Amyloid 2016;23:209-213.
14. Donnelly JP, Hanna M. Cleve Clin J Med 2017;84:12-26.
15. Gonzalez-Lopez E, et al. Rev Esp Cardiol (Engl Ed) 2017;70:991-1004.
16. Castano A, et al. Heart Fail Rev 2015;20:163-178.
17. Shah KB, et al. Circ Heart Fail 2016;9:e002558.
18. Annual Estimates of the Resident Population for Selected Age Groups by Sex for the United States, States, Counties and  Puerto Rico Commonwealth and Municipios: April 1, 2010 to July 1, 2017. US Census Bureau, Population Division. June 2018. Suitland, Suitland-Silver Hill, MD.
19. Taban M, et al. Ophthalmic Plast Reconstr Surg 2004;20:162-165.
20. Geller HI, et al. JAMA 2017;318:962-963.
21. Rubin J, et al. Amyloid 2017;24:226-230.
22. Zivkovic S, et al. Amyloid 2020;27:142-143.
23. Lousada I, et al. Orphanet J Rare Dis 2017;12(Suppl 1):P7
24. Rapezzi C, et al. Nat Rev Cardiol 2010;7:398-408.
25. Invitae. Invitae hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) test.
    Available at: www.invitae.com/en/physician/tests/02265/#info-panel-assay_information.
    Accessed September 2021.
26. Sequeiros J. Orphanet J Rare Dis 2015;10(Suppl 1):120.